Management of Preterm Labor. ACOG Practice Bulletin No. 159. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016 Oct;128(4):e155–64. doi: 10.1097/AOG.0000000000001711.Google Scholar

Prediction and Prevention of Preterm Birth. ACOG Practice Bulletin No. 130. American College of Obstetrician and Gynecologists. Obstet Gynecol 2012 Oct;120(4):964–73.Google Scholar

Management of Late-Term and Postterm Pregnancies. ACOG Practice Bulletin No. 146. American College of Obstetricians and Gynecologists. Obstet Gynecol 2014;1–4.Google Scholar

Kovacevich, GJ, Gaich, SA, Lavin, JP, Hopkins, MP, Crane, SS, Stewart, J, et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am J Obstet Gynecol 2000;182:1089–92.Google Scholar

Sosa, C, Althabe, F, Belizan, JM, Bergel, E. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev. 2004; Issue 1. Art. No.:CD003581. DOI:10.1002/14651858.CD003581,pub2.CrossRefGoogle ScholarPubMed

Maloni, JA. Antepartum bed rest for pregnancy complications: Efficacy and safety for preventing preterm birth. Biol Res Nurs 2010;12:106–24.Google Scholar

Institute of Medicine. Preterm birth: Causes, Consequences and Prevention. Washington, DC: National Academies Press; 2007.Google Scholar

Callaghan, WM, MacDorman, MF, Rasmussen, SA, Win, C, Lackritz, EM. The contribution of preterm birth to infant mortality rates in the United States. Pediatrics 2006;18(4):1566–73.Google Scholar

Spong, CY, Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol 2007;110:405–15Google Scholar

McManemy, J, Cooke, E, Amon, E, Leet, T. Recurent risk for preterm delivery. Am J Obstet Gynecol 2007;110:405–15.Google Scholar

Hickey, CA, Cliver, SP, McNeal, SF, Goldenberg, RL. Low pregravid body mass index as a risk factor for preterm birth: Variation by ethnic group. Obstet Gynecol 1997;89:206–12.Google Scholar

Zhong, Y, Cahill, AG, Macones, GA, Zhu, F, Odibo, AO. The association between prepregnancy maternal body mass index and preterm delivery. Am J Perinatol 2010;27:293–8.Google Scholar

Peaceman, AM, Andrews, WW, Thorp, JM, Cliver, SP, Lukes, A, Iam, JD, et al. Fetal fibronection as a predictor of preterm birth in patients with symptoms: A multicenter trial. Am J Obstet Gynecol 1997;177:13–8CrossRefGoogle Scholar

Swamy, GK, Simhan, HN, Gammill, HS, Heine, RP. Clinical utility of fetal fibronectin for predicting preterm birth. J Reprod Med 2005;50;851–6.Google Scholar

Skoll, A, St. Louis, P, Amiri, N, Delisle, MF, Lalji, S. The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients. J Obstet Gynaecol Can 2006;182:439–42.Google Scholar

Romero, R, Yeo, L, Miranda, J, Hassan, SS, Conde-Agudelo, A, Chaiworapongsa, T. A blueprint for the prevention of preterm birth: Vaginal progesterone in women with a short cervix. J Perinat Med 2013;41(1):27–44.CrossRefGoogle ScholarPubMed

Iams, JD, Goldenberg, RL, Meis, PJ, et al. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med 1996;334(9):567–72.Google Scholar

Owen, J, Yost, N, Berghell, V, et al. National Institute of Child Health and Human Development, Maternal Fetal Medicine Units Network. Mid-trimester endovaginal sonography in women at high risk for spontaneous birth. JAMA 2001;286(11);1340–8.Google Scholar

Fuchs, IB, Henrich, W, Osthues, K, Dudenhausen, JW. Sonographic cervical length in singleton pregnancies with intact membranes presenting with threatened preterm labor. Ultrasound Obstet Gynecol 2004;24:554–7.Google Scholar

Sonek, JD, Iams, JD, Blumenfeld, M, Johnson, F, Landon, M, Gabbe, S. Measurement of cervical length in pregnancy: Comparison between vaginal ultrasonography and digital examiniation. Obstet Gynecol 1990;76:172–5.Google Scholar

Giles, W, Bisits, A, Know, M, Jadsen, G, Smith, R. The effect of fetal fibronectin testing on admission to a tertiary maternal-fetal medicine unit and cost savings. Am J Obstet Gynecol 2000;182;439–42.Google Scholar

Joffe, GM, Jacques, D, Bemis-Heys, R, Burton, R, Skram, B, Shelburne, P. Impact of the fetal fibronectin assay on admission for preterm labor. Am J Obstet Gynecol 1999;180:581–6.Google Scholar

Goldenberg, RL, Culhane, JF, Iams, JD, Romero, R. Epidemiology and causes of preterm birth. Lancet 2008;371:75–84.Google Scholar

Berghella, V, Hayes, E, Visintine, J, Baxter, JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev 2008; Issue 4. Art. No.:CD006843. DOI: 10.1002/14651858. DC006843.Google Scholar

Dyson, DC, Danbe, KH, Bamber, JA, Crites, YM, Field, DR. Maier, JA, et al. Monitoring women at risk for preterm labor. N Engl J Med 1998;338:15–19.Google Scholar

Andrews, WW, Sibai, BM, Thom, EA, Dudley, D, Ernest, JM, McNellis, D, et al. Randomized clinical trial of metronidiazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. National Institute of Child Health & Human Development Maternal Fetal Medicine Unit Network. Obstet Gynecol 2003;101:847–55.CrossRefGoogle Scholar

Meis, PJ, Klebanoff, M, Thom, E, Dombrowski, MP, Sibai, B, Moawad, AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. National Institute of Child Health & Human Development Maternal Fetal Medicine Units Network. N Engl J Med 2003;348:2379–85.Google Scholar

Tita, AT, Rouse, DJ. Progesterone for preterm birth prevention: An evolving intervention. Am J Obstet Gynecol 2009;200:219–24.Google Scholar

Use of progesterone to reduce preterm birth. ACOG Committee Opinion No. 419. American College of Obstetricians and Gynecologists. Obstet Gynecol 2008;112:963–5.CrossRefGoogle Scholar

Cerclage for the Management of Cervical Insufficiency. ACOG Practice Bulletin No. 142. American College of Obstetricians and Gynecologists. Obstet Gynecol 2014 Feb;123(2 Pt 1):372–9. doi: 10.1097/01.AOG.0000443276.68274.Google Scholar

Berghella, V, Figueroa, D, Szychowski, JM, Owen, J, Hankin, GD, Iam, JD, et al. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with a prior preterm birth and a short cervical length. Vaginal Ultrasound Trial Consortium. Am J Obstet Gynecol 2010;202:351:1–6.Google Scholar

Fonseca, EB, Celik, E, Parra, M, Singh, M, Nicolaides, KH. Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007;357:462–9.Google Scholar

Hassan, SS, Romero, R, Vidyadhari, D, Fusey, S, Baxter, JK, Khandelwal, M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: A multicenter, randomized, double-blind, placebo controlled trial. Ultrasound Obstet Gynecol 2011;38:18–31Google Scholar

Midder, ES, Tita, AT, Grobman, WA. Second-trimester cervical length screening among asymotomatic women, an evaluation of risk-based strategies. Obstet Gynecol 2015;126:61–5.Google Scholar

Werner, EF, Han, CS, Pettker, CM, Buhimschi, CS, Copel, JA, Funai, EF, et al. Universal cervical-length screening to prevent preterm birth: A cost-effectiveness analyses. Ultrasound Obstet Gynecol 2001;38:32–7Google Scholar

Cahil, AG, Odibo, AO, Caughey, AB, Stamilio, DM, Hassan, SS, Macones, GA, et al. Universal cervical length screening and vaginal progestereone to prevent preerm birth: A decision and economic analysis. Am J Obstet Gynecol 2010;202:548:1–8.Google Scholar

Lewit, EM, Baker, LS, Corman, H, Shiono, PH. The direct cost of low birth weight. Future Child 1995;5:35–56Google Scholar

Ferguson, JE 2nd, Dyson, DC, Schutz, T, Stevenson, DK. A comparison of tocolysis with nifedipine or ritodrine: Analysis of efficacy and maternal, fetal and neonatal outcome. Am J Obstet Gynecol 1990;163:105–11.Google Scholar

Bracero, LA, Leikin, E, Kirshenbaum, N, Tejani, N. Comparison of nifedipine and ritodrine for the treatment of preterm labor. Am J Perinatol 1991;8:365–9.Google Scholar

Hearne, AE, Nagey, DA. Therapeutic agents in preterm labor: Tocolytic agents. Clin Obstet Gynecol 2000;43:787–801.CrossRefGoogle ScholarPubMed

Anotayanonth, S, Subhedar, NV, Neilson, JP, Harigopal, S. Betamimetics for inhibiting preterm labor. Cochrane Database Syst Rev 2004; Issue 4. Art. No:CD004352. DOI: 10.1002/14651858,CD004352,pub2.Google Scholar

Magnesium Sulfate Use in Obstetrics. The American College of Obstetricians and Gynecologist Committee on Obstetric Practice Society for Maternal-Fetal Medicine. Committee Opinion No. 652.Google Scholar

Periviable Birth. Obstetric Care Consensus No. 3. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:82–94.Google Scholar

Antenatal corticosteroids revisited: Repeat courses. NIH Consensus Statement 2000;17(2):1–18.Google Scholar

Crowther, CA, McKinlay, CJ, Middleton, P, Harding, JE. Repeat doses prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev 2015; Issue 7. Art. No.:DC003935, DOI:10,1002/14651858.CD003935.Google Scholar

Antenatal corticosteroid therapy for fetal maturation. Committee Opinion No. 475. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011; 117:422–4.Google Scholar

Magnesium sulfate use in Obstetrics. Committee Opinion No. 652. The American College of Obstetricians and Gynecologists Committee on Obstetric Practice Society for Maternal-Fetal Medicine. Obstet Gynecol 2016 Jan;127(1):e52–3. doi: 10.1097/AOG.0000000000001267.CrossRefGoogle Scholar

Crowther, CA, Hiller, JE, Doyle, LW, Haslam, RR. Effect of magnesium sulfate given for neuroprotection before preterm birth; a randomized controlled trial. Australasian Collaborative Trial of Magnesium Sulphate (ACTOMgSO₄) Collaborative Group. JAMA 2003;290:2669–76.Google Scholar

Rouse, DJ, Hirtz, DG, Thom, E, Varner, MW, Spong, CY, Mercer, BM, et al. A randomized controlled trial of magnesium sulfate for the prevention of cerebral palsy. Eunice Kennedy Shriver NICHD Maternal Fetal Medicine Units Network. N Engl J Med 2008;359:895–905.CrossRefGoogle Scholar

King, JF, Flenady, V, Papatsonis, D, Dekker, G, Carbonne, B. Calcium channel blocker for inhibiting preterm labour. Cochrane Database Syst Rev 2003; Issue 1. Art. No.: CD002255.DOI: 10.1002/14651858.CD002255;10.1002/14651858.Google Scholar